News: Basilea Pharmaceutica AG (BSLN.S)

BSLN.S on Swiss Exchange

97.75CHF
9:21am EDT
Price Change (% chg)

CHF1.25 (+1.30%)
Prev Close
CHF96.50
Open
CHF97.00
Day's High
CHF98.10
Day's Low
CHF96.70
Volume
31,980
Avg. Vol
107,069
52-wk High
CHF129.80
52-wk Low
CHF66.30

Search Stocks
Select another date:

Wed, Jun 25 2014

UPDATE 1-Basilea shares fall on setback for pneumonia drug in US

ZURICH, June 25 - Shares in Swiss biotech company Basilea fell by as much as 11.5 percent in early trading on Wednesday following a setback to its efforts to gain U.S. approval for its ceftobiprole treatment for pneumonia.

Basilea shares fall after setback for pneumonia treatment in US

ZURICH, June 25 - Shares in Swiss biotech company Basilea fell 8 percent in early trading on Wednesday following a setback to its efforts to gain U.S. approval for its ceftobiprole treatment for pneumonia.

BRIEF-Basilea Pharmaceutica gives update on ceftobiprole's U.S. regulatory status

June 25 - Basilea Pharmaceutica AG : * Says FDA confirmed that a potential regulatory approval of ceftobiprole in

Basilea starts early-stage study with Gram-negative antibiotic

ZURICH, June 12 - Swiss biotech company Basilea said it had started an early-stage clinical study of an antibiotic to treat infections with multi-drug resistant Gram-negative bacteria in combination with another drug.

Select another date:
Search Stocks